These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 33932096)

  • 1. Benzo[a]phenazine derivatives: Promising scaffolds to combat resistant Mycobacterium tuberculosis.
    Halicki PCB; da Silva EN; Jardim GAM; Almeida RG; Vicenti JRM; Gonçalves BL; da Silva PEA; Ramos DF
    Chem Biol Drug Des; 2021 Sep; 98(3):352-362. PubMed ID: 33932096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quinonoid and phenazine compounds: synthesis and evaluation against H37Rv, rifampicin and isoniazid-resistance strains of Mycobacterium tuberculosis.
    Carneiro PF; Pinto Mdo C; Coelho TS; Cavalcanti BC; Pessoa C; de Simone CA; Nunes IK; de Oliveira NM; de Almeida RG; Pinto AV; de Moura KC; da Silva PA; da Silva Júnior EN
    Eur J Med Chem; 2011 Sep; 46(9):4521-9. PubMed ID: 21820768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naphthoquinones isolated from Diospyros anisandra exhibit potent activity against pan-resistant first-line drugs Mycobacterium tuberculosis strains.
    Uc-Cachón AH; Borges-Argáez R; Said-Fernández S; Vargas-Villarreal J; González-Salazar F; Méndez-González M; Cáceres-Farfán M; Molina-Salinas GM
    Pulm Pharmacol Ther; 2014 Feb; 27(1):114-20. PubMed ID: 23968826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and antimycobacterial evaluation of novel adamantane and adamantanol analogues effective against drug-resistant tuberculosis.
    Alsayed SSR; Lun S; Payne A; Bishai WR; Gunosewoyo H
    Bioorg Chem; 2021 Jan; 106():104486. PubMed ID: 33276981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel N-aryl- and N-heteryl phenazine-1-carboxamides as potential agents for the treatment of infections sustained by drug-resistant and multidrug-resistant Mycobacterium tuberculosis.
    De Logu A; Palchykovska LH; Kostina VH; Sanna A; Meleddu R; Chisu L; Alexeeva IV; Shved AD
    Int J Antimicrob Agents; 2009 Mar; 33(3):223-9. PubMed ID: 19070992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro investigation of the antimicrobial activities of novel tetramethylpiperidine-substituted phenazines against Mycobacterium tuberculosis.
    van Rensburg CE; Jooné GK; Sirgel FA; Matlola NM; O'Sullivan JF
    Chemotherapy; 2000; 46(1):43-8. PubMed ID: 10601797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimycobacterial activity of acetone extract and isolated metabolites from folklore medicinal lichen Usnea laevis Nyl. against drug-sensitive and multidrug-resistant tuberculosis strains.
    Tatipamula VB; Annam SSP
    J Ethnopharmacol; 2022 Jan; 282():114641. PubMed ID: 34536516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of β-lapachone derivatives against rifampicin-susceptible and -resistant strains of Mycobacterium tuberculosis.
    Coelho TS; Silva RS; Pinto AV; Pinto MC; Scaini CJ; Moura KC; Almeida da Silva P
    Tuberculosis (Edinb); 2010 Sep; 90(5):293-7. PubMed ID: 20663716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and investigation on the structure-activity relationships of N-substituted 2-aminothiazole derivatives as antitubercular agents.
    Pieroni M; Wan B; Cho S; Franzblau SG; Costantino G
    Eur J Med Chem; 2014 Jan; 72():26-34. PubMed ID: 24333612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. QSAR-driven design, synthesis and discovery of potent chalcone derivatives with antitubercular activity.
    Gomes MN; Braga RC; Grzelak EM; Neves BJ; Muratov E; Ma R; Klein LL; Cho S; Oliveira GR; Franzblau SG; Andrade CH
    Eur J Med Chem; 2017 Sep; 137():126-138. PubMed ID: 28582669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triazolophthalazines: Easily Accessible Compounds with Potent Antitubercular Activity.
    Veau D; Krykun S; Mori G; Orena BS; Pasca MR; Frongia C; Lobjois V; Chassaing S; Lherbet C; Baltas M
    ChemMedChem; 2016 May; 11(10):1078-89. PubMed ID: 27097919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and anti-tubercular activity of novel alkyl substituted riminophenazine derivatives.
    Li YL; Zhang CL; Zhang DF; Lu Y; Wang B; Zheng MQ; Li C; Yin DL; Huang HH
    Yao Xue Xue Bao; 2012 Jun; 47(6):745-54. PubMed ID: 22919722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitubercular activity of quinolizidinyl/pyrrolizidinylalkyliminophenazines.
    Tonelli M; Novelli F; Tasso B; Sparatore A; Boido V; Sparatore F; Cannas S; Molicotti P; Zanetti S; Parapini S; Loddo R
    Bioorg Med Chem; 2014 Dec; 22(24):6837-45. PubMed ID: 25464882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of (-)-Camphene Derivatives Against Mycobacterium tuberculosis in Acidic pH.
    de Carvalho HC; Ieque AL; Valverde TL; Baldin VP; Meneguello JE; Campanerut-Sá PAZ; Vandresen F; Ghiraldi Lopes LD; Passos Souza MR; Santos NCS; Dias Siqueira VL; Caleffi-Ferracioli KR; Lima Scodro RB; Cardoso RF
    Med Chem; 2021; 17(5):485-492. PubMed ID: 31702530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hybrid Design of Isonicotinic Acid Hydrazide Derivatives: Machine Learning Studies, Synthesis and Biological Evaluation of their Antituberculosis Activity.
    Kovalishyn V; Hodyna D; Sinenko VO; Blagodatny V; Semenyuta I; Slivchuk SR; Brovarets V; Poda G; Metelytsia L
    Curr Drug Discov Technol; 2020; 17(3):365-375. PubMed ID: 30973110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. QSAR based design of new antitubercular compounds: improved isoniazid derivatives against multidrug-resistant TB.
    Martins F; Ventura C; Santos S; Viveiros M
    Curr Pharm Des; 2014; 20(27):4427-54. PubMed ID: 24245762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo antimycobacterial activities of ketone and amide derivatives of quinoxaline 1,4-di-N-oxide.
    Villar R; Vicente E; Solano B; Pérez-Silanes S; Aldana I; Maddry JA; Lenaerts AJ; Franzblau SG; Cho SH; Monge A; Goldman RC
    J Antimicrob Chemother; 2008 Sep; 62(3):547-54. PubMed ID: 18502817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of 5-methylpyrimidopyridone analogues as selective antimycobacterial agents.
    Wu Y; Cheung CY; Zhou Y; Wang Z; Tu Z; Cook GM; Lu X
    Bioorg Med Chem; 2021 Nov; 49():116426. PubMed ID: 34624820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of a new class of isonicotinoylhydrazones used alone and in combination with isoniazid, rifampicin, ethambutol, para-aminosalicylic acid and clofazimine against Mycobacterium tuberculosis.
    De Logu A; Onnis V; Saddi B; Congiu C; Schivo ML; Cocco MT
    J Antimicrob Chemother; 2002 Feb; 49(2):275-82. PubMed ID: 11815568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.